bullish
J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways
324 Views02 Apr 2020 18:57
In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion12 Jun 2020
- Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas29 Apr 2020
- TPG and KKR in Race to Buy 20% Stake in Piramal’s Pharma Business Valued Over US$2bn08 Apr 2020
- J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways02 Apr 2020
- Japan’s AGC Launches Voluntary Tender Offer on Italian Biotech Firm Molmed18 Mar 2020
- Japan’s Astellas Pharma to Buy Audentes Therapeutics to Expand into Gene Therapy Market04 Dec 2019
x